Stille

Stille P/B

The P/B (Price-to-Book Ratio) of Stille (STIL.ST) as of Oct 24, 2026 is 2.23. In the previous year, P/B (Price-to-Book Ratio) was 2.25 — a change of -1.31% (lower).

P/B

2.23

YoY

-1.31%

Last updated:

P/B (Price-to-Book Ratio) of Stille is 2025 2.23 . P/B (Price-to-Book Ratio) of Stille was 2024 2.25 . It decreases by -1.31% lower compared to the previous year.

The Stille P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
18.32 SEK
Jan 1, 2019
15.31 SEK
Jan 1, 2020
14.20 SEK
Jan 1, 2021
10.65 SEK
Jan 1, 2022
8.31 SEK
Jan 1, 2023
2.49 SEK
Jan 1, 2024
2.25 SEK
Jan 1, 2025
2.23 SEK
The Stille P/B history
YEARP/BYoY
2.23-1.31%
2.25-9.60%
2.49-69.98%
8.31-21.97%
10.65-25.02%
14.20-7.23%
15.31-16.43%
18.32-17.30%
22.15-12.47%
25.30-21.41%
32.19-21.51%
41.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

P/B (Price-to-Book Ratio) of Stille is 2.23 in 2025.

P/B (Price-to-Book Ratio) of Stille changed from 2.25 to 2.23, representing a -1.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Stille since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Stille

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Stille